RESILIA Tissue Mechanism of Action

Edwards Lifesciences

Clinical Outcomes of Balloon Expandable Valves in Small Annuli: The …

Edwards Lifesciences

A. Abbas

Contemporary Results with the Latest Generation Balloon Expandable V…

Edwards Lifesciences

C. Stinis

Durability: What does the patient care about?

Edwards Lifesciences

V. Thourani

One Million Patients

Edwards Lifesciences

Lifetime Management - Your First Move Defines the Next

Edwards Lifesciences

J. McCabe, V. Thourani, T. Jones, P. Villablanca

Live Case: TAV-in-TAV in Severe Aortic Stenosis Patient

New York Transcatheter Valves 2023

S. Sharma, A. Kini, S. Lerakis, G. Dangas

RESILIA Tissue Mechanism of Action

Edwards Lifesciences

The UPSTREAM Management of Aortic Stenosis in the Future

ARCH Advanced Revascularization Symposium

M. Leon

Cerebral Embolization During Protected TAVR: Case Study Using Trans …

Houston Methodist DeBakey Heart and Vascular Center

A. Lumsden, M. Reardon, N. Kleiman, K. Sinha, Z. Garami

Lifetime Management of the "Younger" Patient with Aortic Stenosis

Scripps Health

G. Fontana

Cerebral Embolic Protection & TAVR Outcomes: Where Does the Data Lea…

Scottsdale Interventional Forum 2021

S. Iyengar

Cerebral Protection for TAVR: When and Why

Scripps Health: 2019 Eighth Annual Structural Heart Intervention and Imaging

D. Rizik

Valve Replacement for Pure Native Aortic Regurgitation from Alpha to…

Patrick Serruys

Embolic Protection for All

Scottsdale Interventional Forum 2023

S. Yakubov

TCT 2023 Insights: Effectiveness of Cerebral Embolic Protection in T…

TCT 2023 Insights

O. Koren

My Worst TAVR Complication… And What I Learned From It

Scripps 9th Annual Structural Heart Intervention and Imaging 2020: A Practical Approach

C. Stinis

My Most Valve-in-Valve: TAVR in TAVR

University of Miami

L. Cressa

Salvaging a TAVR Disaster

ARCH Advanced Revascularization Symposium

J. Hermiller

Single Operator TAVR: That’ll Be a Huge Mistake!!!

Scottsdale Interventional Forum 2023

K. Grubb